NOT KNOWN FACTS ABOUT INSULIN RESSITANCE

The only therapy readily available for clients with leprechaunism to date is recombinant IGF1, aiming to avoid compensatory hyperinsulinemia (23). IGF has about the 6% from the glucose-lowering action impact of insulin and it has the same structure to it, consequently it will be able to bind to insulin receptors triggering peripheral glucose uptake